James K
banner
jkimberdo.bsky.social
James K
@jkimberdo.bsky.social
#ACHD Cardiologist, advocate for #DEI and #equalrights. Here to share kindness, goodness, beauty (and cardiology of course). Posts are my own opinions, and not those of my employer, and posts are not to be interpreted as medical advice. (He/Him) 🫀🌈🦄
Reposted by James K
Now out in #AHAJournals Most studies focus on the association between socioeconomic disadvantage and 30-day Heart Failure readmissions, our work focuses on the cumulative impact on patient outcomes after diagnosis. #CardioSky #MedSky #HF @ahajournals.bsky.social www.ahajournals.org/doi/abs/10.1...
November 25, 2024 at 1:53 PM
November 25, 2024 at 1:50 AM
Reposted by James K
#EHJCVI 🔎 Association between subclinical atherosclerosis burden and unrecognized #MI detected by #whyCMR in middle-aged low risk adults

🇪🇸 #PESA 🫀 Ischaemic scar 👉 ⬆️ SCORE2 ⬆️ CACS and peripheral subclinical atherosclerosis

Read more 👉 doi.org/10.1093/ehjc...

#CardioSky #MedSky
November 23, 2024 at 11:10 AM
It is well known that the LGBT population is at higher risk for development of cardiovascular disease, but pay extra attention to the risks specific to our patients undergoing gender affirmation therapies

pubmed.ncbi.nlm.nih.gov/38958699/
Transgender healthcare: metabolic outcomes and cardiovascular risk - PubMed
Transgender identity is often associated with gender dysphoria and minority stress. Gender-affirming hormone treatment (GAHT) includes masculinising or feminising treatment and is expected to be lifel...
pubmed.ncbi.nlm.nih.gov
November 22, 2024 at 12:07 AM
Albert Schweitzer taught us to live for each other
November 21, 2024 at 1:37 AM
It’s never too early for a Harry Potter Xmas village.
November 20, 2024 at 12:10 AM
ALL OF THIS
November 19, 2024 at 6:02 PM
Reposted by James K
And yes, this study demonstrated a causal link
November 17, 2024 at 10:10 PM
“SGLT2i generally seem safe, well-tolerated, and potentially beneficial in patients with ACHD. SGLT2i was associated with a 3-fold reduction in the 6-month HF hospitalization rate.”

pubmed.ncbi.nlm.nih.gov/38530688/
Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease - PubMed
SGLT2i generally seem safe, well-tolerated, and potentially beneficial in patients with ACHD. SGLT2i was associated with a 3-fold reduction in the 6-month HF hospitalization rate. These results warran...
pubmed.ncbi.nlm.nih.gov
November 19, 2024 at 2:37 AM
With the recent studies about gpts outperforming physicians, I thought it would be fun to have AI show me a diagram of Fontan circulation… nice try gpt
November 19, 2024 at 2:10 AM
November 19, 2024 at 2:00 AM
Thrilled to expand awareness of Congenital Heart Disease and promote the work Penn State is doing with the new Congenital Heart Center! Check out our webchat, and check out our program!

www.abc27.com/penn-state-h...
Penn State Health Nov. 14th Heart Webchat 2024
Learn about congenital heart defects and meet the team at Penn State Health Congenital Heart Center on “Heart to Heart” Thursday, Nov. 14th at 7:30 p.m. on abc27. Plus, hear about the l…
www.abc27.com
November 19, 2024 at 12:55 AM
Todays reading: The Warmth of Other Suns
November 17, 2024 at 7:19 PM
Inaugural Post: Let us fill the sky with the light of a billion brilliant stars
November 16, 2024 at 11:26 PM